Home
Key Data
Bayer Stock
Management Report
Overview of Sales, Earnings and Financial Position
Economic Outlook
Sales and Earnings Forecast
Corporate Structure
Performance by Subgroup, Segment and Region
HealthCare
CropScience
MaterialScience
Performance by Region
Calculation of EBIT(DA) Before Special Items
Core Earnings Per Share
Financial Position of the Bayer Group
Growth and Innovation
HealthCare
CropScience
MaterialScience
Employees
Opportunities and Risks
Events After the Reporting Period
Financial Statements
Income Statements
Comprehensive Income
Financial Position
Statements of Cash Flows
Changes in Equity
Notes
Key Data by Segment
Key Data by Region
Explanatory Notes
Focus
News
Overview
Perfect solutions for potato growers
New therapeutic options in interventional medicine
Mosquito nets exceed requirements
E.U. registration for Xarelto recommended
New opportunities in rice research
Bayer plans continued growth in Japan
Affordable contraceptive
Milestone in wheat genome research
New growth strategy for CropScience
Research center for the factory of the future
Help in the battle against tuberculosis
Effective, broad-spectrum weed control in soybeans
Multiple accolades for Bayer Annual Report
Cancer drug prolongs survival
Technology improves energy efficiency
Targeted insertion of gene into cotton
Services
Overview
Download Center
News of the third quarter 2011
Bayer HealthCare
E.U. registration for Xarelto recommended
» more
Bayer CropScience
New growth strategy for CropScience
» more
Bayer MaterialScience
Technology improves energy efficiency
» more
News overview
Focus
Top in climate protection and sustainability
Bayer is a world leader in climate protection. This is confirmed by the company’s renewed inclusion in two global indices.
» more
Key Data
Bayer Group
The Bayer Group continued its successful development in the third quarter of 2011. Read more about Net Sales, EBITDA, EBIT, Net income, Cash flow, Non-operating result, Number of Employees.
» more
Bayer Stock
Investor Information
Stock markets around the world fell sharply in the third quarter of 2011. Bayer shares dropped by 25.2%, while the DAX was down 25.4%.
» more
Management Report
Overview of Sales, Earnings and Financial Position
On a currency- and portfolio-adjusted basis, sales rose by 4.8% to €8.7 billion, with the emerging markets accounting for a disproportionately large share of growth.
» more
Financial Statements
Bayer Group Consolidated Income Statements
Comprehensive income, financial position, Bayer Group consolidated statements of cash flows.
» more
Print page
Search
Search
Download Center
Complete
Stockholder's Newsletter
(
PDF
2049 KB)
Add to Download Center
Your Selection:
Links
Financial Reports
Publications
Annual Reports
Sustainable Development Reports
Services
Order print version
Event Reminder
Press Newsletter
Quarterly Reports Newsletter
SMS Service
Bayer Links
Bayer Global
Bayer HealthCare
Bayer CropScience
Bayer MaterialScience
Bayer Business Services
Bayer Technology Services
Currenta
Special Interest
Investor Relations
Press
Jobs and Career
Foundations
Social Media
» Bayer Group
Deutsch
Sitemap
Search
RSS
Contact
zoom +
normal view 100%
zoom -